In the latest startup financing, Wuxi Vision Pro Ltd., an ophthalmic medical device maker, has secured RMB 80 million ($12.6 million) in a Series B round of financing from Qiming Venture Partners and Ruijian Capital. In another development, Shanghai-based Shenma Online Financial Information Service has raised RMB 300 million ($47.2 million) in a Series C funding round.
Wuxi Vision nabs $12.6m funding
Wuxi Vision Pro Ltd., a China-based ophthalmic medical device maker, on Friday announced raising RMB 80 million ($12.6 million) in a Series B round of financing from Qiming Venture Partners and Ruijian Capital.
Liao Xiugao, founder of Wuxi Vision Pro Ltd., said: “With modern science and technology drastically changing human behaviors, excessive use of the human eyes has accelerated the aging of eyes and developing other eye disease among young people. These factors promote the need of rapid development of ophthalmic medical products.”
Founded in 2010, Wuxi Vision has its own lens materials development and manufacturing facility in Irvine, California, USA. The company focuses on research and development, production, and marketing of intraocular lenses. Its Leiming brand aspheric intraocular lenses has obtained CFDA approval and CE certificate, Wuxi said in a statement.
Shenma Financial secures $47.2m funding
Shanghai-based financing solutions provider Shenma Online Financial Information Service has raised RMB 300 million ($47.2 million) in a Series C funding round jointly led by Tongbanjie Fintech Group, China Growth Capital, and Hina Group.
The round also saw participation from CreditEase New Finance Industry Investment Fund and ChinaEquity Group.
Founded in 2015, Shenma Financial provides financial services addressing the transportation needs of rural users. It provides short-term and mid-term credit products including install payment services allowing farmers to purchase electric scooters for use on the farm.